24/7
Buzz
Startups
VC
AI
Innovation
Opinions
Events
Promising Startups 2024
BiblioTech
Boarding Pass
Corporate
Appointments
CTalk
Tech Gateways
2025 VC survey
@Finance
Ctech Testimonials
Shopping
Projects
Spotlight
About
Newsletter
Contact us
Facebook
Twitter
ACCESSIBILITY
by
Homepage
CEO
Tags search
HOME
24/7
buzz
STARTUPS
VC
AI
Innovation
OPINIONS
EVENTS
SHOPPING
ABOUT
teram of use
Privacy Policy
NEWSLETTER
SEARCH
CONTACT US
ACCESSIBILITY
24/7
Headlines
17:40
Inside the new AI jobs: How companies are hiring and what they’re paying
16:00
Tenable appoints Vlad Korsunsky as CTO and Managing Director of Tenable Israel
15:00
Viola Ventures raises $250 million to back Israel’s next tech wave
14:35
Israeli tech’s dual reality: Mega deals vs. rapid AI exits
More stories
Buzz
Most popular
Daily
Weekly
1
“Younger people are getting cancer more and more. We have to make kinder medicines.”
2
Shipping giant MSC submits bid for ZIM, challenging Hapag-Lloyd in takeover race
3
ServiceNow in advanced talks to acquire Armis at around $7 billion valuation
4
The $2.3 billion mystery arms deal Israel won’t explain
5
Armis sale to ServiceNow could yield $4 billion windfall for Insight Partners
More news
CEO
5 stories about CEO
Security Contractor Magal Appoints New CEO
12.04.18
|
Amarelle Wenkert
Dror Sharon is set to replace Saar Koursh, who was appointed CEO in 2015
Digital Marketing Company Matomy Media Replaces CEO after Ten Months
09.01.18
|
Lilach Baumer
Current CEO Sagi Niri has carried out a reorganization plan in 2017, selling non-core assets and streamlining the company's operations
Pharma Veteran Julian Adams takes Helm at Gamida Cell
21.11.17
|
Lilach Baumer
The Novartis-backed company is developing a universal bone marrow transplant solution for patients unable to find a donor
New Teva CEO Kåre Schultz to Relocate to Israel
17.10.17
|
Golan Hazani
Mr. Schultz, who led Copenhagen-based H. Lundbeck A/S since 2015, will come to Israel and assume his new position by the end of the month
Teva Appoints Lundbeck's Schultz as CEO
11.09.17
|
Dror Reich and Micky Grunfeld
The company’s announcement brings an end to a seven month search for a CEO to lead the troubled generic drugmaker. Updated
Previous Articles